Bill > HB4344

This bill, known as the Michael Brandon Cochran Act, mandates specific medical testing for unconscious or severely hypoglycemic patients in hospital intensive care units (ICUs), which are specialized hospital units for critically ill patients needing close monitoring. Hospitals must administer a C-peptide test, which measures a protein related to insulin production, to patients who are unconscious or have dangerously low blood sugar (hypoglycemia, defined as below 50 mg/dl). This testing is required even if the patient doesn't have a known diabetes-related condition. Additionally, if a patient dies after ICU treatment with symptoms suggesting brain damage or prolonged unconsciousness, a post-mortem C-peptide test must be performed. Hospitals failing to comply face a $10,000 fine per violation from the Office of Health Facility Licensure and Certification (OHFLAC). The bill also establishes the Michael Brandon Cochran Grant Program, administered by the Department of Health Facilities, to help hospitals cover the costs of these C-peptide tests and related staff training. Funding for these grants will come from a dedicated Michael Brandon Cochran Fund, which can receive state appropriations, private donations, and other sources, with any unspent funds carrying over to the next fiscal year.

Justice

http://www.wvlegislature.gov/Bill_Status/Bills_history.cfm?input=4344&year=2026&sessiontype=RS&btype=bill